ERIS LIFESCIENCES
Back to Balance Sheet
|
ERIS LIFESCIENCES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹229 Cr | ₹227 Cr | ₹-16 Cr | ₹-197 Cr | ₹-151 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of ERIS LIFESCIENCES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹229 Cr |
| Mar2024 | ₹227 Cr |
| Mar2023 | ₹-16 Cr |
| Mar2022 | ₹-197 Cr |
| Mar2021 | ₹-151 Cr |
How is Deferred Tax Assets / Liabilities of ERIS LIFESCIENCES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹229 Cr | 0.87 | |
| Mar2024 | ₹227 Cr | Positive | |
| Mar2023 | ₹-16 Cr | Negative | |
| Mar2022 | ₹-197 Cr | Negative | |
| Mar2021 | ₹-151 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of ERIS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ERIS LIFESCIENCES | ₹18,458.7 Cr | -3.8% | -2.8% | -7.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,735.0 Cr | -0.6% | 10.3% | 4.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,312.0 Cr | 1.4% | 11% | 11.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,369.0 Cr | -1.5% | 3.3% | 37.6% | Stock Analytics | |
| CIPLA | ₹107,205.0 Cr | -2.6% | 7.9% | -13.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,592.0 Cr | -3.2% | 2.7% | 10.6% | Stock Analytics | |
ERIS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ERIS LIFESCIENCES | -3.8% |
-2.8% |
-7.4% |
| SENSEX | -4.3% |
-2.6% |
-7.6% |
You may also like the below Video Courses